A multicentre randomized double blind placebo controlled trial of myocardial angiogenesis using VEGF165 intramyocardial gene delivery in patients with severe angina pectoris

Trial Profile

A multicentre randomized double blind placebo controlled trial of myocardial angiogenesis using VEGF165 intramyocardial gene delivery in patients with severe angina pectoris

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Aug 2006

At a glance

  • Drugs Vascular endothelial growth factor gene therapy (Primary)
  • Indications Angina pectoris
  • Focus Therapeutic Use
  • Acronyms Northern-Trial
  • Most Recent Events

    • 30 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top